Viatris Inc 's Revenue in the fiscal year 2025 $ 14,299.90 millions
Viatris Inc 's Revenue in the fiscal year 2024 $ 14,739.30 millions
Viatris Inc 's Revenue in the fiscal year 2023 $ 15,426.90 millions
Viatris Inc 's Revenue in the fiscal year 2022 $ 16,262.70 millions
Viatris Inc 's Revenue in the fiscal year 2021 $ 17,886.30 millions
VTRS Revenue third quarter 2026 Y/Y Growth Comment
Viatris Inc reported decrease in Revenue in the third quarter 2026 by -0.28% to $ 3,749.50 millions, from the same quarter in 2025. The decrease in the third quarter 2026 Viatris Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 2.29%.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 137 other companies have achieved higher Revenue growth. While Viatris Inc ' s Revenue decline of -0.28% ranks overall at the positon no. 2891 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Viatris Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
301.94 %
9.14 %
-62.91 %
(Dec 31 2020)
VTRS's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Viatris Inc disclosed decrease in Revenue from the second quarter by -0.19% to $ 3,749.50 millions, from $ 3,756.80 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.
Within Major Pharmaceutical Preparations industry 85 other companies have achieved higher Revenue quarter on quarter growth. While Viatris Inc 's Revenue growth quarter on quarter, overall rank is 1851.
In the III. Quarter 2026 Viatris Inc disclosed decrease in Revenue from the second quarter by -0.19% to $ 3,749.50 millions, from $ 3,756.80 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.
Within Major Pharmaceutical Preparations industry 85 other companies have achieved higher Revenue quarter on quarter growth. While Viatris Inc 's Revenue growth quarter on quarter, overall rank is 1851.
Viatris Inc 's 12 Months Revenue Growth Year on Year
With 4.4% annual Revenue growth, Viatris Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.
In the Healthcare sector 420 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2499, from total ranking in previous quarter at 3343.
With 4.4% annual Revenue growth, Viatris Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.
In the Healthcare sector 420 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2499, from total ranking in previous quarter at 3343.
About Viatris Inc Revenue Growth Rates (VTRS), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
